Condition
ALL (Acute B-Lymphoblastic Leukemia) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 ALL (Acute B-Lymphoblastic Leukemia) clinical trials that are recruiting, at sites in 2 countries (most in China (3), South Korea (1)). By phase: Phase 1/2 (1), Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest ALL (Acute B-Lymphoblastic Leukemia) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Blinatumomab plus low-dose donor cells after transplant for high-risk B-ALL | Phase 1 | Beijing | Recruiting | Jul 1, 2026 |
| Universal CAR‑T (CT1190B) for CD19 and/or CD20 positive relapsed/refractory B‑cell acute lymphoblastic leukemia in patients aged 12–75 | Early Phase 1 | Wuhan, Hubei | Recruiting | Mar 13, 2026 |
| Sulforaphane to speed blood‑cell recovery after long‑frozen cord‑blood transplant | — | Tianjing | Recruiting | Dec 22, 2025 |
| Efficacy and safety of CRC01 for adult patients with large B-cell lymphoma | Phase 1/2 | Seoul and 1 other locations | Recruiting | Apr 8, 2021 |
All recruiting trials (4)
-
Blinatumomab plus low-dose donor cells after transplant for high-risk B-ALL
This small, early-phase study tests whether giving blinatumomab with low-dose donor lymphocytes after allogeneic transplant is safe and helps long-term survival for people with high-risk B-ALL.
-
Universal CAR‑T (CT1190B) for CD19 and/or CD20 positive relapsed/refractory B‑cell acute lymphoblastic leukemia in patients aged 12–75
This trial will test whether an off‑the‑shelf CAR‑T product (CT1190B) is safe and can induce remission in CD19 and/or CD20 positive relapsed or refractory B‑cell acute lymphoblastic leukemia for patients aged 12–75.
-
Sulforaphane to speed blood‑cell recovery after long‑frozen cord‑blood transplant
This trial tries sulforaphane to see if it helps adults with high‑risk AML, ALL, or MDS recover blood cells faster after receiving cord blood units frozen for 10 years or more.
-
Efficacy and safety of CRC01 for adult patients with large B-cell lymphoma
This study is testing a new CAR-T therapy called CRC01, combined with other medications, to see if it can help adults with hard-to-treat large B-cell lymphoma feel better.
Related topics
Quick answers
How many ALL (Acute B-Lymphoblastic Leukemia) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (3 trials), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.